Doximity, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Doximity, Inc. on May 13, 2026. The filing primarily announces the appointment of new executive leadership and references the release of financial results for the fiscal quarter and year ended March 31, 2026.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained in the press release attached as Exhibit 99.1, which is incorporated by reference but not detailed within the body of this 8-K document.
Material Changes and Executive Appointments
Effective May 13, 2026, Doximity announced significant changes to its executive leadership:
- Chief Financial Officer: Matthew Sonefeldt was appointed as CFO. He succeeds Siddharth Sitaram, who will serve as interim Principal Financial Officer until June 7, 2026. Mr. Sonefeldt brings 25 years of experience, including recent roles at Docusign, Atlassian, and LinkedIn.
- President: Steven L. Zatz, M.D., was appointed as President. Dr. Zatz previously served as CEO of HealthCentral Corporation and held executive roles at WebMD Health Corp.
Compensation and Contract Details
The filing discloses the following compensation terms for the new appointees:
| Executive | Base Salary | Annual Incentive Bonus | Initial Equity Grant (RSUs) | Performance Equity Grant (RSUs) |
|---|---|---|---|---|
| Matthew Sonefeldt (CFO) | $400,000 | $400,000 | $9,000,000 (3-year vest) | $3,000,000 (3-year vest) |
| Steven L. Zatz, M.D. (President) | $400,000 | $500,000 | $1,000,000 (1-year vest) | $1,700,000 (1-year vest) |
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future performance, or a discussion of risks and contingencies. The document states that the financial results referenced in Item 2.02 are not deemed "filed" for purposes of Section 18 of the Exchange Act.
Key Facts for Investor Verification
- Review Exhibit 99.1 (Press Release) for actual Q4 and FY 2026 financial results, as this 8-K does not list specific revenue or earnings figures.
- Verify the transition timeline for the Principal Financial Officer role, with Siddharth Sitaram serving in an interim capacity until June 7, 2026.
- Note the significant equity compensation packages granted to the new CFO and President, totaling $12 million and $2.7 million respectively in initial and performance-based RSUs.
- Confirm the strategic rationale for appointing a physician executive (Dr. Zatz) as President, given his background in digital health and advertising.